First, we found multiple MAGE family proteins (e.g., MAGEC2, MAGEB2, MAGEC1, MAGEB6) with a gene expression profile similar to those in clinical trials (MAGEA1, MAGEA4), which have been reported to be tumor specific.50 Here, MAGEA1 is linked to neoplasm.